3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
17
Head & Neck
2
Genitourinary
2
Other
1
Classical hematology
1
Conditions
Leukemia, Myeloid, Acute
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Neoplasms
29
Myelodysplastic Syndromes
24
Multiple Myeloma
22
Lymphoma, Non-Hodgkin
20
Anemia
20
Hodgkin Disease
19
Anemia, Refractory, with Excess of Blasts
19
Leukemia
18
Anemia, Aplastic
18
Leukemia, Lymphocytic, Chronic, B-Cell
17
Hematologic Neoplasms
17
Febrile Neutropenia
17
Venous Thromboembolism
16
Anemia, Sickle Cell
16
Lymphoma, Follicular
15
Myeloproliferative Disorders
14
Lymphoma, Mantle-Cell
14
Primary Myelofibrosis
13
Lymphoma
12
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
12
Thrombocytopenia
11
Lymphoma, Large B-Cell, Diffuse
11
Burkitt Lymphoma
11
Leukemia, Myelomonocytic, Chronic
10
Leukemia, Myeloid, Chronic-Phase
10
Congenital Abnormalities
10
Neoplasms, Plasma Cell
9
Lymphoma, Large-Cell, Immunoblastic
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Crohn Disease
×
Classical hematology
×
Clear all
NCT02965209
2018-02-14
ENMSET
Evangelisches Krankenhaus Düsseldorf
Phase NA
Completed
136 enrolled